| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Divisions of Biology [L. S., C. I., A. D. R.] and Immunology [F-S. C., R. J. P., J. E. S.], Beckman Research Institute of the City of Hope, Duarte, California 91010, and Department for Clinical Chemistry and Pathobiochemistry, University of Technology, D-5100 Aachen, Federal Republic of Germany [M. N., F-J. G.]
Carcinoembryonic antigen (CEA) is one of the best characterized tumor-associated antigens and is extensively used in the in vitro immunodiagnosis of human colon adenocarcinomas. Among a number of anti-CEA monoclonal antibodies, the murine monoclonal antibody T84.66 shows the highest specificity and affinity for CEA and has been used successfully for in vivo tumor imaging in mice and humans. We report here the cloning and sequencing of the genes coding for monoclonal antibody T84.66 and the amino acid sequence of the variable regions for the heavy and light chains. We also report the construction of mouse/human chimeric IgG1 antibody genes using T84.66 variable region genes and human constant region genes. The resulting chimeric gene constructs were transfected into murine myeloma cells (Sp2/0) by electroporation and into Chinese hamster ovary cells by lipofection. The chimeric antibodies obtained exhibited the same specificity and affinity for CEA as that of the T84.66 immunoglobulin produced by the murine hybridoma cell line. Antibody concentrations in culture medium supernatants were clonally variable but similar (15480 ng/ml) for both Sp2/0 and Chinese hamster ovary transfectants; the average production by Chinese hamster ovary transfectants was only 35-fold less than Sp2/0 transfectants. Ascites production of Sp2/0 transfectants is sufficiently high (900 µg/ml) for initial in vivo studies with humanized T84.66.
1 This research was supported by a program project Grant CA 43904 from the National Cancer Institute. M. N. is supported by Bundes Ministerium für Forschung und Technologie Grant 01GA8712.
2 To whom requests for reprints should be addressed, at Division of Immunology, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010-0269.
Received 6/ 6/89.
Revised 12/ 7/89.
This article has been cited by other articles:
![]() |
H.-J. Li, M. Everts, L. Pereboeva, S. Komarova, A. Idan, D. T. Curiel, and H. R. Herschman Adenovirus Tumor Targeting and Hepatic Untargeting by a Coxsackie/Adenovirus Receptor Ectodomain Anti-Carcinoembryonic Antigen Bispecific Adapter Cancer Res., June 1, 2007; 67(11): 5354 - 5361. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schwegler, A. Dorn-Beineke, S. Nittka, C. Stocking, and M. Neumaier Monoclonal Anti-idiotype Antibody 6G6.C4 Fused to GM-CSF Is Capable of Breaking Tolerance to Carcinoembryonic Antigen (CEA) in CEA-Transgenic Mice Cancer Res., March 1, 2005; 65(5): 1925 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kenanova, T. Olafsen, D. M. Crow, G. Sundaresan, M. Subbarayan, N. H. Carter, D. N. Ikle, P. J. Yazaki, A. F. Chatziioannou, S. S. Gambhir, et al. Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti-Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments Cancer Res., January 15, 2005; 65(2): 622 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. C. Wong, D. Z. Chu, L. E. Williams, D. M. Yamauchi, D. N. Ikle, C. S. Kwok, A. Liu, S. Wilczynski, D. Colcher, P. J. Yazaki, et al. Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer Clin. Cancer Res., August 1, 2004; 10(15): 5014 - 5021. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Yazaki, M. A. Sherman, J. E. Shively, D. Ikle, L. E. Williams, J. Y.C. Wong, D. Colcher, A. M. Wu, and A. A. Raubitschek Humanization of the anti-CEA T84.66 antibody based on crystal structure data Protein Eng. Des. Sel., May 1, 2004; 17(5): 481 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sundaresan, P. J. Yazaki, J. E. Shively, R. D. Finn, S. M. Larson, A. A. Raubitschek, L. E. Williams, A. F. Chatziioannou, S. S. Gambhir, and A. M. Wu 124I-Labeled Engineered Anti-CEA Minibodies and Diabodies Allow High-Contrast, Antigen-Specific Small-Animal PET Imaging of Xenografts in Athymic Mice J. Nucl. Med., December 1, 2003; 44(12): 1962 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. C. Wong, S. Shibata, L. E. Williams, C. S. Kwok, A. Liu, D. Z. Chu, D. M. Yamauchi, S. Wilczynski, D. N. Ikle, A. M. Wu, et al. A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5842 - 5852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Wu, G. J. Tan, M. A. Sherman, P. Clarke, T. Olafsen, S. J. Forman, and A. A. Raubitschek Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange Protein Eng. Des. Sel., December 1, 2001; 14(12): 1025 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. C. Wong, D. Z. Chu, D. M. Yamauchi, L. E. Williams, A. Liu, S. Wilczynski, A. M. Wu, J. E. Shively, J. H. Doroshow, and A. A. Raubitschek A Phase I Radioimmunotherapy Trial Evaluating 90Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies Clin. Cancer Res., October 1, 2000; 6(10): 3855 - 3863. [Abstract] [Full Text] |
||||
![]() |
C. Vaquero, M. Sack, J. Chandler, J. Drossard, F. Schuster, M. Monecke, S. Schillberg, and R. Fischer Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves PNAS, September 28, 1999; 96(20): 11128 - 11133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Wu, P. J. Yazaki, S.-w. Tsai, K. Nguyen, A.-L. Anderson, D. W. McCarthy, M. J. Welch, J. E. Shively, L. E. Williams, A. A. Raubitschek, et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment PNAS, July 18, 2000; 97(15): 8495 - 8500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |